Spire Wealth Management Exelixis, Inc. Transaction History
Spire Wealth Management
- $2.83 Billion
- Q2 2024
A detailed history of Spire Wealth Management transactions in Exelixis, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 810 shares of EXEL stock, worth $21,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
810Holding current value
$21,327% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding EXEL
# of Institutions
459Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$882 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$781 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$714 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$399 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$332 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.47B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...